Asthma is a disease of the lungs that affects people of all ages and both sexes. About 1 in 13 people in the United States ...

Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types. Developments in biologic therapies for ...

Current estimates suggest that approximately half of people with severe asthma have the eosinophilic subtype, which is ...

T2-low asthma remains largely underserved. “The current treatment landscape for severe asthma has made significant strides, ...

Flare-ups can range from mild to severe and can be an emergency. A good asthma treatment plan will minimize flare-ups and enable you to stop them when they occur. Learn more about asthma flare-ups, ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

The study highlights T2-low and T17-high asthma endotypes in minoritized youths, offering insights for precision medicine and ...

Changes Due to Corticosteroids Corticosteroids, in inhaled and oral (tablet or liquid) form, are a common treatment for asthma, especially when symptoms are moderate to severe. One study found that 95 ...

There is an urgent need for improved diagnostic tools and targeted therapies to address the gap in care for patients with ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Researchers at the University of Pittsburgh have developed a new nasal swab test that identifies specific asthma subtypes in ...